Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | MME | P08473 | 3/20 | 0.50 |
| ▸ | ACE | P12821 | 2/20 | 0.50 |
| ▸ | CPA1 | P15085 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | GGT1 | P19440 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 5/20 | 0.47 |
| ▸ | MMP1 | P03956 | 2/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249802 | 1.00 | BCHE (0.54) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL3143813 | 1.00 | BCHE (0.54) | BCHEFAAHMMEACECPA1 | |
| Water SCHEMBL28808740 | 0.98 | BCHE (0.53) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL21585496 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL28403707 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL6702717 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL16465927 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL6702715 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL3953856 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 | |
| SCHEMBL17626995 | 0.98 | FAAH (0.55) | BCHEFAAHMMEACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4226918-A1 | PHARMACEUTICAL SINGLE DOSAGE FORM FOR ORAL DELIVERY OF PEPTIDES | Majewski, Filip (PL) | 2023-08-16 | — | — | EP | claimed |
| EP-4199968-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | Ambrx, Inc. (US) | 2023-06-28 | — | — | EP | claimed |
| CN-114788791-A | Compositions and methods for improving the appearance of skin | 宝洁公司 | 2022-07-26 | — | — | CN | claimed |
| WO-2022040596-A1 | ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF | AMBRX, INC. (US) | 2022-02-24 | — | — | WO | claimed |
| EP-3923991-A1 | COMPOSITIONS CONTAINING, METHODS AND USES OF ANTIBODY-TLR AGONIST CONJUGATES | Ambrx, Inc. (US) | 2021-12-22 | — | — | EP | claimed |
| EP-3844188-A1 | ANTI-CD3 ANTIBODY FOLATE BIOCONJUGATES AND THEIR USES | Ambrx, Inc. (US) | 2021-07-07 | — | — | EP | claimed |
| WO-2020168017-A1 | COMPOSITIONS CONTAINING, METHODS AND USES OF ANTIBODY-TLR AGONIST CONJUGATES | AMBRX, INC. (US) | 2020-08-20 | — | — | WO | claimed |
| EP-3630977-A1 | METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION | Ambrx, Inc. (US) | 2020-04-08 | — | — | EP | claimed |
| WO-2020047176-A1 | ANTI-CD3 ANTIBODY FOLATE BIOCONJUGATES AND THEIR USES | AMBRX, INC. (US) | 2020-03-05 | — | — | WO | claimed |
| WO-2018223108-A1 | METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION | AMBRX, INC. (US) | 2018-12-06 | — | — | WO | claimed |
| US-5856579-A | Adduct salts of novel substituted benzylamines and a process for optically resolving them | AJINOMOTO CO., INC. (JP) | 1999-01-05 | — | — | US | claimed |
| EP-0776883-A1 | Adduct salts of substituted benzylamine and a process for optically resolving them | Ajinomoto Co., Inc. (JP) | 1997-06-04 | — | — | EP | claimed |
| EP-0198397-B1 | METHOD OF PRODUCING L-PHENYLALANINE | KURARAY CO., LTD. (JP) | 1993-01-07 | — | — | EP | claimed |
| EP-0174375-B1 | PROCESS FOR PREPARING N-ACYLPHENYLALANINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-05-02 | — | — | EP | claimed |
| EP-0161796-B1 | PROCESS FOR PRODUCING N-ACYLPHENYLALANINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-03-08 | — | — | EP | claimed |
| US-4675439-A | CATALYTIC REDUCTION OF N-ACYL-B-PHENYLSERINE | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1987-06-23 | — | — | US | claimed |
| US-4612388-A | Process for producing N-acylphenylalanines | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1986-09-16 | — | — | US | claimed |
| EP-0174375-A1 | PROCESS FOR PREPARING N-ACYLPHENYLALANINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-03-19 | — | — | EP | claimed |
| EP-0161796-A1 | Process for producing N-acylphenylalanines | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1985-11-21 | — | — | EP | claimed |
| US-4151198-A | Resolution of N-acyl-DL (+)-phenylalanines | AMERICAN CYANAMID COMPANY (US) | 1979-04-24 | — | — | US | claimed |